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Hereditary hearing loss (HHL) is a common disorder characterized by a huge genetic
heterogeneity. The definition of a correct molecular diagnosis is essential for proper
genetic counseling, recurrence risk estimation, and therapeutic options. From 20 to
40% of patients carry mutations in GJB2 gene, thus, in more than half of cases it is
necessary to look for causative variants in the other genes so far identified (∼100). In
this light, the use of next-generation sequencing technologies has proved to be the
best solution for mutational screening, even though it is not always conclusive. Here
we describe a combined approach, based on targeted re-sequencing (TRS) of 96 HHL
genes followed by high-density SNP arrays, aimed at the identification of the molecular
causes of non-syndromic HHL (NSHL). This strategy has been applied to study 103 Italian
unrelated cases, negative for mutations in GJB2, and led to the characterization of 31%
of them (i.e., 37% of familial and 26.3% of sporadic cases). In particular, TRS revealed
TECTA and ACTG1 genes as major players in the Italian population. Furthermore, two
de novo missense variants in ACTG1 have been identified and investigated through
protein modeling and molecular dynamics simulations, confirming their likely pathogenic
effect. Among the selected patients analyzed by SNP arrays (negative to TRS, or with
a single variant in a recessive gene) a molecular diagnosis was reached in ∼36% of
cases, highlighting the importance to look for large insertions/deletions. Moreover, copy
number variants analysis led to the identification of the first case of uniparental disomy
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involving LOXHD1 gene. Overall, taking into account the contribution of GJB2, plus the
results from TRS and SNP arrays, it was possible to reach a molecular diagnosis in
∼51% of NSHL cases. These data proved the usefulness of a combined approach for
the analysis of NSHL and for the definition of the epidemiological picture of HHL in the
Italian population.
Keywords: targeted re-sequencing, SNP arrays, hereditary hearing loss, italian families, molecular diagnosis
INTRODUCTION
Hearing loss (HL) is a frequent disease affecting 1–3 in
every 1,000 live births (Jecˇmenica et al., 2015). It is typically
described based on its clinical presentation and can be
classified by a number of different factors, such as the
age of onset, severity, etiology, and pathobiology (Rehm
and Morton, 1999; Dror and Avraham, 2009; Alford et al.,
2014; Smith et al., 2014; Parker and Bitner-Glindzicz,
2015).
Overall, 60–70% of cases have a genetic etiology (Nishio
et al., 2015) and can be further categorized as to whether
the gene causes only hearing loss (non-syndromic or NSHL)
or multiple clinical features (syndromic). NSHL accounts
for the vast majority of hereditary HL cases and includes,
according to the pattern of inheritance, autosomal recessive
cases (∼80%, labeled as “DFNB”), autosomal dominant (∼20%,
labeled as “DFNA”) X-linked or mitochondrial cases (<1%)
(Stelma and Bhutta, 2014). In Italy, from 20 to 40% of cases
are caused by mutations in GJB2 gene (Cama et al., 2009;
Primignani et al., 2009; Salvago et al., 2014), making it the
major player. However, as expected, considering the unique
and complex structure of the inner ear, many other genes
have been found to be involved in the hearing phenotype.
To date, 158 NSHL loci (60 DFNA loci, 88 DFNB loci, 6
X-linked loci, 2 modifier loci, 1 Y-linked locus, and 1 locus for
auditory neuropathy), and 95 genes (27 DFNA genes, 56 DFNB
genes, 8 DFNA/DFNB genes, and 4 X-linked genes) have been
reported as causative (Hereditary Hearing Loss Homepage;
http://hereditaryhearingloss.org/). In this light, a combined
approach based on an accurate clinical characterization
and on different analytical technologies represents the most
effective strategy for the identification of the molecular cause
of NSHL, which is essential for proper genetic counseling,
recurrence risk estimation, prognosis, and therapeutic
options.
Here, we report the results obtained on a large cohort of
unrelated patients (N = 103), negative for GJB2 mutations,
applying a targeted re-sequencing panel of 96 HHL genes
followed by SNP arrays in negative cases. This approach
allowed: (1) the characterization of 31% of all NSHL cases,
leading to an overall detection rate of ∼51% (together with
GJB2), (2) the identification of an extremely rare case of
uniparental disomy (UPD) in HHL (i.e., the first one in
LOXHD1 gene), (3) the demonstration of the importance of copy
number variants (CNVs), and (4) the identification of 17 new
alleles.
MATERIALS AND METHODS
Ethical Statement
All patients provided written informed consent forms for
both genetic counseling and molecular genetic testing prior to
enrolment. Written informed consent was obtained from the
next of kin on behalf of the minors/children involved in this
study. The study was approved by the Institutional Review
Board of IRCCS Burlo Garofolo, Trieste, Italy. All research was
conducted according to the ethical standard as defined by the
Helsinki Declaration.
Patients: Clinical Evaluation and Sample
Collection
A total of 103 Italian unrelated NSHL patients have been
recruited in the following centers (ENTs or Medical Genetics):
Trieste (IRCCS Burlo Garofolo), Milano (IRCCS Cà Granda—
Ospedale Maggiore Policlinico), Torino (A.O.U. Citta della
Salute e della Scienza), Cesena (AUSL Romagna–Cesena), and
Bologna (Policlinico S.Orsola-Malpighi). Inclusion criteria were:
(1) absence of vestibular signs, (2) no obvious syndromic features,
(3) absence of diabetes, cardiovascular diseases, visual problems,
and neurological disorders, (4) absence of mutations in GJB2,
GJB6, andMTRNR1 genes.
All participants underwent pure tone audiometric testing
(PTA) or auditory brainstem response (ABR) in order to
characterize the severity of HL according to the International
guidelines described by Clark (1981).
Based on the pedigree structure, cases were divided into
sporadic (N = 57) and familial (N = 46), the latter being classified
as autosomal recessive (AR) (N = 4), autosomal dominant
(AD) (N = 14), X-linked dominant (N = 1), and Y-linked
(N = 1). The remaining 27 cases had an unclear pattern of
inheritance.
At least three to four individuals per family have been analyzed
by sequencing (both affected and healthy), and for the sporadic
cases both the proband and the parents have been sequenced.
Targeted Resequencing (TRS) Hereditary
Hearing Loss Panel
The 96 hearing loss genes panel described by Vozzi et al. has
been used in this study (Vozzi et al., 2014). DNA libraries were
constructed using Ion AmpliSeqTM Library Kit 2.0 (Thermo
Fisher Scientific), and run on the Ion Torrent Personal Genome
Machine (PGM) System (Thermo Fisher Scientific), according to
manufacturer’s instructions.
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TABLE 2 | Inheritance pattern and phenotypic data of all families and sporadic cases positive to TRS and/or SNP array.
ID Inheritance pattern Type of HL
Familial case_1 AR Early-onset bilateral symmetric moderate NSHL
Familial case_2 AD Early-onset bilateral symmetric mild to moderate NSHL
Familial case_3 AD Early-onset bilateral symmetric moderate to severe NSHL
Familial case_4 AD Adult-onset bilateral symmetric severe to profound NSHL
Familial case_5 AD Early-onset bilateral symmetric severe to profound progressive NSHL
Familial case_6 AR Early-onset bilateral symmetric moderate NSHL
Familial case_7 AD Adult-onset bilateral symmetric moderate high frequencies NSHL
Familial case_8 AD Early-onset bilateral symmetric moderate to severe NSHL
Familial case_9 AR Early-onset bilateral symmetric moderate to profound medium-high frequencies NSHL (Sky-slope)
Familial case_10 AR Early-onset bilateral symmetric moderate to severe NSHL
Familial case_11 AD Early-onset bilateral symmetric moderate to severe NSHL
Familial case_12 AD Early-onset bilateral symmetric mild to moderate progressive NSHL
Familial case_13 AD Early-onset bilateral symmetric severe to profound NSHL
Familial case_14 AD Early/adult-onset, bilateral symmetric moderate NSHL at the low and high frequencies
Familial case_15 XL Early-onset bilateral symmetric severe to profound medium-high frequencies NSHL
Familial case_16 AD Adult-onset bilateral symmetric moderate NSHL
Familial case_17 AD Early-onset bilateral symmetric moderate to severe NSHL
Sporadic case_1 – Early-onset bilateral symmetric severe to profound medium-high frequencies NSHL
Sporadic case_2 – Early-onset bilateral symmetric severe to profound medium-high frequencies NSHL (Sky-slope)
Sporadic case_3 – Early-onset bilateral symmetric severe to profound NSHL
Sporadic case_4 – Early-onset bilateral symmetric severe to profound NSHL
Sporadic case_5 – Early-onset bilateral symmetric profound NSHL
Sporadic case_6 – Early-onset bilateral symmetric moderate to severe NSHL (Sky-slope)
Sporadic case_7 – Early-onset bilateral symmetric moderate to severe NSHL
Sporadic case_8 – Early-onset bilateral symmetric severe NSHL
Sporadic case_9 – Early-onset bilateral symmetric moderate to severe NSHL
Sporadic case_10 – Early-onset bilateral symmetric mild to moderate NSHL
Sporadic case_11 – Early-onset bilateral symmetric profound NSHL
Sporadic case_12 – Early-onset bilateral symmetric profound NSHL
Sporadic case_13 – Early-onset bilateral symmetric mild to moderate NSHL
Sporadic case_14 – Early-onset bilateral symmetric moderate to severe NSHL
Sporadic case_15 – Early-onset bilateral symmetric moderate NSHL
AR, autosomal recessive inheritance; AD, autosomal dominant inheritance; XL, X-linked pattern of inheritance; –, unclear pattern of inheritance. Hearing loss has been classified according
to the following criteria: slight, 16–25 dB (dB); mild, 26–40 dB; moderate, 41–55 dB; moderately severe, 56–70 dB; severe, 71–90 dB; profound, 91 dB or more.
Data Analysis
TRS data were analyzed with Ion Torrent SuiteTM v4.0 software,
set up with standardized parameters. Single Nucleotides
Variations (SNVs) and Small Insertions and Deletions
(INDELs) were collected into a standardized Variant Call
Format (VCF) version 4.1 (Danecek et al., 2011). SNVs
and INDELS were then annotated with ANNOVAR (Wang
et al., 2010) using human genome build 19 (hg19) as the
reference.
SNVs leading to synonymous amino acids substitutions
not predicted as damaging and not affecting highly
conserved residues were excluded, as well as SNVs/INDELs
with quality score (QUAL) <20 and called in off-target
regions.
A comparison between the identified genetic variants and data
reported in NCBI dbSNP build150 (http://www.ncbi.nlm.nih.
gov/SNP/) as well as in gnomAD (http://gnomad.broadinstitute.
org/), and NHLBI Exome Sequencing Project (ESP) Exome
Variant Server 1 led to the exclusion of those variants previously
reported as polymorphism. In particular, a Minor Allele
Frequency (MAF) cut off of 0.01 and one of 0.001 were used for
recessive and dominant cases, respectively.
The pathogenicity of known genetic variants was evaluated
using ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/), Deafness
Variation Database (http://deafnessvariationdatabase.org/) as
well as The Human Gene Mutation Database (http://www.hgmd.
cf.ac.uk/ac/index.php).
On the other hand, for novel variants, several in silico tools,
such as PolyPhen-2 (Adzhubei et al., 2013), SIFT (Ng and
Henikoff, 2003), MutationTaster (Schwarz et al., 2010), LRT
(Chun and Fay, 2009), CADD score (Kircher et al., 2014) were
used to evaluate the pathogenicity of the variant identified.
Moreover, the evolutionary conservation of residues across
1[Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle,
WA]. Available online at: http://evs.gs.washington.edu/EVS/
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FIGURE 1 | Causative genes identified in our cohort of Italian patients. The graph shows the distribution of the causative genes detected by TRS and SNP arrays.
species was evaluated by PhyloP (Pollard et al., 2010) and GERP
(Cooper et al., 2005) scores.
Human Splicing Finder (HSF) version 2.4.1 (http://www.umd.
be/HSF/) (Desmet et al., 2009) and Splice Site Prediction by
Neural Network (NNSPLICE) version 9 (www.fruitfly.org) were
used to predict the effect of the splice-site mutations.
We manually investigated the raw sequence reads for all the
candidate pathogenic variants using the Integrative Genomics
Viewer (IGV) (Thorvaldsdottir et al., 2013) with the purpose of
excluding likely false positive calls due to read misalignment.
Finally, on a patient-by-patient basis, identified variants were
discussed in the context of phenotypic data at interdisciplinary
meetings and themost likely disease-causing SNVs/INDELs were
analyzed by direct Sanger sequencing on a 3500 Dx Genetic
Analyzer (Applied Biosystems), using ABI PRISM 3.1 Big Dye
terminator chemistry (Applied Biosystems).
Sanger sequencing was employed also to perform the
segregation analysis within the family.
SNP Arrays Analysis
SNP arrays analysis was performed using the Human
OmniExpress Exome-8 Bead Chip (Illumina Inc., San Diego,
CA, United States) containing 960,919 loci derived from phases
I, II and III of the International HapMap project. The array
includes over 274,000 functional exonic markers, delivering
unparalleled coverage of putative functional exonic variant
selected from 12,000 individual exome and whole-genome
sequences. A total of 200 ng of gDNA (50 ng/µl) for each sample
was processed according to Illumina’s Infinium HD Assay Super
protocol. Normalization of raw image intensity data, genotype
clustering, and individual sample genotype calls were performed
using Illumina’s Genome Studio software v2011.1 (cnvpartition
3.2.0). The CNVs were mapped to the human reference genome
hg19 and annotated with UCSC RefGene. Allele detection and
genotype calling were performed with Genome Studio software,
B allele frequencies (BAFs) and log R ratios were exported as text
files for PennCNV analysis (Wang et al., 2007).
Protein Modeling and Molecular Dynamics
Simulation
The protein structure for the modeling of two de novo variants
of ACTG1 was collected from the protein data bank (PDB,
http://www.rcsb.org/pdb/) (PDB ID: 5JLH) (von der Ecken et al.,
2016). The wild-type (WT) structure was used to generate the
mutational models p.(Thr66Ile) and p.(Arg183Gln) with PyMOL
(www.pymol.org). The WT and mutant structures were used
in GROMACS (Groningen Machine for Chemical Simulation
V 4.5.4 package) (Van Der Spoel et al., 2005; Hess et al.,
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2008) for molecular dynamics simulations. The GROMOS96
(van Gunsteren., 1996) force field was applied to the structures.
Energy minimization was carried out using the steepest descent
algorithm with a tolerance of 2,000 kJ/mol/nm. The energy-
minimized structures were used for the molecular dynamics
simulations. The SPC3 (Berendsen et al., 1981) water model was
used for solvation in a cubic box (0.8 nm) with periodic boundary
conditions applied in all directions. The simulation systems were
neutralized by adding counter ions. A twin range cut-off was used
for long-range interactions: 0.8 nm for van derWaals interactions
and 1.4 nm for electrostatic interactions. All bond lengths were
constrained with the LINCS algorithm (Hess et al., 1997). The
SETTLE algorithm (Miyamoto and Kollman, 1992) was applied
to constrain the geometry of the water molecules. The energy
minimized system was subjected to 100 ps equilibration followed
by 10 ns productionmolecular dynamics simulations with a time-
step of 2 fs at constant temperature (300K), pressure (1 atm) and
number of particles, without any position restraints (Berendsen
et al., 1984). The collected trajectories were analyzed using the
tools within GROMACS and the structures were analyzed using
PyMOL. In addition, the representative structures were selected
from molecular dynamics simulations for the structural analyses
using the cluster analysis (Krishnamoorthy et al., 2018) and
surface mapping calculations.
RESULTS
Targeted Re-sequencing (TRS)
For the 96 genes under investigation an average 95% of the
targeted region was covered at least 20X, with a 337 mean-
depth. A total of 170 Mbp of raw sequence data was produced
per individual. We identified an average of 468 genetic variants
(SNVs/INDELs) per subject. After applying the filtering pipeline
described in the “Methods” section, an average of 17 residual
SNVs/INDELs for each subject were obtained.
A likely pathogenic variant was found in 27 cases (15 familial
out of 46 and 12 sporadic out of 57) (Table 1) leading to an overall
detection rate of ∼33% of the familial cases and ∼21% of the
sporadic ones. A summary of the phenotypic and genetic data of
the TRS positive cases is reported in Tables 1,2 respectively.
Causative mutations in the following genes were identified:
ACTG1, CDH23, DFNA5, KCNQ4, LOXHD1, MYH14, MYO1A,
MYO6, MYO7A, MYO15A, OTOA, PDZD7, POU3F4, POU4F3,
SLC26A4, SMPX, TECTA, TMPRSS3, andWFS1 (Figure 1).
A detailed summary of pathogenic variants identified in our
screening is reported in Table 1. Overall, 23 already known
mutations and 16 novel variants have been detected as here
detailed: 30 missense (two de novo in ACTG1, and one in
MYO1A), four frameshift deletions, one frameshift insertion, one
non-sense, three variants affecting splice-sites.
Moreover, since 14 familiar and sporadic cases were carrying
only one causative allele (i.e., an already known pathogenic
mutation or a variant predicted as highly damaging) in an
autosomal recessive gene (Table 3), we hypothesized that a
second mutation, or a large CNV, has been missed in trans.
In this light, these individuals have been further investigated
with SNP arrays and the most interesting results are reported
below.
TECTA
Combining previous data (Vozzi et al., 2014) with the results of
the present study, TECTA (NM_005422.2) has been identified
as the major NSHL gene in the Italian population (after GJB2),
characterizing 13% of positive cases (with both autosomal
dominant and recessive pattern of inheritance; Figure 2). Four
different alleles in Familial case_8 [c.775G>C; p.(Gly259Arg)],
Familial case_13 (c.6000-1G>T) and Sporadic case_8 [c.6000-
1G>A; c.2020C>T; p.(Gln674∗)] (Table 1), plus one already
described [c.589G>A; p.(Asp197Asn)] in Vozzi et al. (Familial
case_2) have been identified.
All patients show an early onset symmetrical NSHL, with
different degrees of severity (Table 2 and Figure 2). The
identified variants, predicted as damaging by several in silico
predictor tools, affect functional domains of the α-tectorin (the
entactin (ENT)-like, zonadhesin (ZA), and zona pellucida (ZP)
domains) and involve highly conserved residues. Two of these
changes [c.589G>A, p.(Asp197Asn); c.775G>C, p.(Gly259Arg)]
were already known for causing NSHL, while the remaining
three [c.6000-1G>T; c.6000-1G>A; c.2020C>T, p.(Gln674∗)]
have been identified in the present study.
Two different splicing variants affecting the same nucleotide
have been identified in Familial case_13 and Sporadic case_8.
SinceTECTA gene is expressed at low levels in peripheral blood, it
was not possible to test their effect on mRNA processing directly
on the patients samples, however, according to the prediction
of Human Splicing Finder software (http://www.umd.be/HSF3/)
the c.6000-1G>T allele causes the total loss of the acceptor splice
site, while the c.6000-1G>A leads to the loss of the acceptor splice
site, together with the creation of a new site one nucleotide after.
ACTG1
Three alleles in ACTG1 (NM_001199954.1) have been identified:
two are novel, [c.847A>G; p.(Met283Val) in Familial case_4,
c.197C>T, p.(Thr66Ile) in Sporadic case_13] while one was
already described [c.548G>A; p.(Arg183Gln) in Sporadic
case_6]. All variants affect the actin-binding domain of ACTG1
protein. Patients display various degrees of severity of hearing
loss (from mild-moderate, to severe-profound) and different
age of onset (both adult-onset and early-onset), as expected
from autosomal dominant NSHL (Table 2, Figure 3). Overall
mutations in ACTG1 characterize 11% of all cases in our cohort
(Table 1).
Since ACTG1 de novo mutations are a rare cause of NSHL
(Wang et al., 2018), protein modeling and molecular dynamics
simulations of these two variants have been performed.
The structural stability of the WT and of the ACTG1 mutants
was dynamically calculated using root mean square deviation
(RMSD). Results showed that the deviation pattern was different
for the mutants compared to theWT (Figure 3C-a); in particular,
the p.(Thr66Ile) mutant deviated less than the WT, while
the p.(Arg183Gln) mutant deviated more than the WT. This
behavior correlates with the average number of hydrogen bonds,
which are needed for protein’s structural stability (Figure 3C-b).
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FIGURE 2 | Pedigrees and audiograms of patients carrying variants in TECTA gene. (A–D) Phenotypic details of all patients carrying pathogenic variants in TECTA
gene. Filled symbols represent affected individuals.
Here, p.(Thr66Ile) displayed an increased number of hydrogen
bonds compared to both the WT and the p.(Arg183Gln)
mutant and this explains the stable/rigid structural nature of
p.(Thr66Ile). On the other hand, the p.(Arg183Gln) mutant
showed a decrease in the number of hydrogen bonds that might
result in an increased protein flexibility (Figure 3C-a).
The representative structures from molecular dynamics
simulations showed that the mutational spots for both
Thr66 and Arg183 are located in the binding region of
the tropomyosin (Figure 3D). Results showed that the
mutant p.(Thr66Ile), which is very close to the D-loop,
causes a conformational change of the loop itself that alters
the binding surface, while in the case of p.(Arg183Gln),
both the tropomyosin-binding region and the D-loop are
involved leading to a potential cavity on the binding surface
(Figures 3E,F).
These results proved that both variants affect a key-binding
region, introducing few critical changes in the structure.
POU4F3 and SMPX
Three families with an X-linked pattern of inheritance have been
detected (Figure 4).
Familial case_15 carries a novel frameshift deletion
[c.162delG; p.(Lys55Serfs∗25)] in SMPX gene (NM_014332.2),
known for causing dominant X-linked NSHL (Table 1), The
proband presents post-lingual bilateral symmetric severe to
profound medium-high frequencies HL, while the mother shows
a monolateral profound to severe HL (Figure 4A). As expected,
no preferential X-inactivation has been detected in subject I:2.
POU4F3 (NM_000307.4), known for causing recessive X-
linked HL, was found to be mutated in Sporadic Case_9
(c.989G>A, p.(Arg330Lys) and Sporadic Case_14 (c.967C>G,
p.(Arg323Gly) (Table 1). Both variants affect the HOX domain
of the protein and are predicted to be damaging. In particular,
the c.967C>G, p.(Arg323Gly) allele, was already known to
cause hearing loss (Cremers et al., 2000). Both patients display
early-onset bilateral symmetric moderate to severe hearing
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FIGURE 3 | Phenotypic features of patients carrying variants in ACTG1 gene and molecular modeling of ACTG1 de novo variants. (A,B) Pedigrees and audiograms of
patients carrying de novo variants in ACTG1. Filled symbols represent affected individuals. (C) Trajectory based analyses of the WT and mutants (a) structural stability
and (b) intra-molecular interactions, (D–F) (a) Cartoon and (b) surface models for the representative structures from molecular dynamics simulations. Here, WT is
labeled with structural features and the p.(Thr66Ile) and p.(Arg183Gln) mutations are labeled as sticks colored in pink and teal, respectively. The structurally and
functionally important D-loop is shown in red.
loss, with perilymphatic gusher occurred during cochleostomy
(Figures 4B,C).
SNP Arrays
Cases negative to TRS, or those showing a single variant in
recessive genes, were analyzed with SNP arrays.
LOXHD1
In the present study we identified the second case of UPD
ever described associated with HL, in a patient (Sporadic
case_4) showing an early-onset bilateral symmetric severe
to profound NSHL (Figure 5A). Briefly, TRS revealed a
novel homozygous mutation in LOXHD1 (NM_144612.6)
[c.3071A>G; p.(Tyr1024Cys)], apparently segregating only
from the father. The variant was predicted as damaging by
all in silico predictor tools and affected the LH2 domain
of the protein. SNP array analysis identified one run
of homozygosity bigger than 8Mb in length, spanning
LOXHD1 gene on chromosome 18. Analysis of informative
SNPs in parental samples and their comparison with the
patient’s genotype confirmed the presence of a paternal
UPD. Moreover, a deep analysis of SNPs on the whole
chromosome 18 confirmed the presence of both the small
isodisomy segment spanning the LOXHD1 gene plus the
presence of heterodisomy on the remaining parts of Chr18
(Figure 5B).
OTOA
In Sporadic case_1, showing early-onset bilateral symmetric
severe to profound medium-high frequencies hearing loss, a
homozygous missense variant [c.1865T>A; p.(Leu622His),
rs750007142] in OTOA gene (NM_144672.3) was detected.
The variant, predicted as damaging by all in silico
predictor tools, apparently segregated only from the
father, thus the clinical case was further investigated by
SNP array. Data analysis led to the identification of a
large (∼228.5 Kb) heterozygous submicroscopic 16p12.2
deletion inherited from the mother (Fontana et al.,
2017).
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FIGURE 4 | Pedigrees and audiograms of patients with X-linked HHL. (A) Patients of Familial case_15 carry a frameshift deletion in SMPX gene. (B-C) Sporadic
case_9 and 14 carry two missense variant in POU4F3 gene. Filled symbols represent affected individuals.
STRC and CATSPER2
In Familial Case_6 and Sporadic Case_15 two different deletion
involving STRC gene (NM_153700.2) have been identified
(Figures 5C–F). The first one belongs to an AR family composed
of 4 members, 2 affected siblings (a 5-year old girl and a 3-year
old boy) and their normal hearing parents. Both children showed
a bilateral moderate symmetric SNHL characterized by a pre-
lingual onset (Figure 5C). A 49.23Kb deletion on chromosome
15 spanning through STRC and CATSPER2 (NM_172095.2)
genes was identified (Figure 5D). In the second case, a 10 y.o.
girl affected by early-onset bilateral symmetric moderate NSHL,
with no familiarity for HL (Figure 5E), an homozygous deletion
of 49Kb involving only STRC gene has been detected (Figure 5F).
MYO6
In Familial Case_16 SNP arrays led to the identification of a
novel heterozygous deletion affecting MYO6 gene, known for
causing autosomal dominant NSHL. The family is composed of
two affected siblings (37 and 35 y.o., respectively), the healthy
mother (64 y.o.) and the affected father (80 y.o.). All affected
individuals display adult onset bilateral moderate symmetric
SNHL (Figure 5G) and carry a deletion of 75.8 Kb inMYO6 gene
(Figure 5H).
Overall, the combination of an accurate clinical
characterization, TRS and SNP arrays, led to the identification
of the molecular cause of hearing loss in 31% of cases (37% of
familial cases and 26.3% of sporadic cases). Moreover, among
the 14 patients analyzed with SNP array (negative to TRS, or
with a single variant in a recessive gene) we reached a molecular
diagnosis in∼36% of cases (5 out of 14).
DISCUSSION
Nowadays, the use of targeted re-sequencing in routine clinical
diagnosis seems to be one of the most accurate approaches for
the molecular diagnosis of highly heterogeneous genetic diseases,
such as inherited deafness. Nevertheless, this approach has some
limitations, not being able to accurately detect rearrangements
such as deletions and duplications (i.e., CNVs) which might be
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FIGURE 5 | Pedigree, audiograms, and SNP array data of cases carrying pathogenic CNVs. (A) Pedigree and audiometric features of Sporadic case_4. Filled
symbols represent affected individuals. (B) SNP array analysis of LOXHD1 gene: results of SNP array on the proband show a UPD with ROH region (reported in green)
suggesting a recombination event originated in meiosis I. The log R ratio of the analysis is consistent with normal copy number. Some of the markers in both the
telomeric regions 18p and 18q plus in the ROH region are also indicated. (C) Pedigree and audiometric features of Familial case_6. Filled symbols represent affected
individuals. (D) SNP array analysis: the image shows a double deletion (CNV = 0) of 49.23Kb in the q15.3 region of chromosome 15 (highlighted in red). The deletion
includes STRC and CATSPER2 genes. (E) Pedigree and audiometric features of Sporadic case_15. Filled symbols represent affected individuals. (F) SNP array
analysis: the graph shows a double deletion (CNV = 0) of 49Kb in the q15.3 region of chromosome 15 (highlighted in red). Deletion includes STRC gene. (G) Pedigree
and audiometric features of Familial case_16. Filled symbols represent affected individuals. (H) SNP arrays analysis: the image shows a deletion (CNV = 1) of 75.8Kb
in the q14.1 region of chromosome 6 (highlighted in orange). In the deletion region is possible to see a loss of heterozygosity in the B allele frequency and a lowering of
the log ratio under the zero (about −0.66). This deletion includes MYO6 gene.
involved in causing a significant proportion of genetic disorders
(Yang et al., 2013). Moreover, recent studies have also suggested
that runs of homozygosity (ROH) are much more frequent than
previously recognized and, in some cases, can unravel UPD
(Wang et al., 2015).
To overcome this limitation and to further increase the
detection rate of HHL cases, we refined our strategy performing
high-density SNP arrays in TRS-negative cases. Results
confirmed that a multi-step integrated approach based on TRS
followed by SNP arrays, is extremely powerful in advancing the
molecular characterization of HHL. In particular, the largest
study of Italian HHL patients so far carried out, demonstrates
the importance of SNP arrays analysis in detecting the first
case of UPD in LOXHD1 gene and confirming the importance
of genomic rearrangements in the etiopathogenesis of hearing
loss.
Combining TRS and SNP arrays, our strategy allowed to
characterize 31% of the ∼65% of cases negative to GJB2
mutations (leading to an overall detection rate -including GJB2–
of ∼51%). These results seem to be in agreement with previous
data reported by Shearer and Smith (2015) and Sloan-Heggen
et al. (2015) in which a detection rate of 39% (including
GJB2 gene) in a much larger cohort is described. Moreover,
results of the present study demonstrated a higher detection
rate in familial cases (37%), mainly characterized by autosomal
dominant inheritance, compared to sporadic cases (26.3%). Also
in this case, these data were in agreement with those reported in
the literature (71% for familial cases and 37% for sporadic cases)
(Shearer et al., 2011; Sloan-Heggen et al., 2016).
Our study highlights the importance of TECTA as the second
most frequently mutated gene in the Italian population, following
GJB2. Patients affected by TECTA mutations display an early
onset symmetrical NSHL, with different degrees of severity (from
mild-moderate, to severe-profound). According to literature
data, we identified different genotype-phenotype correlations
depending on the inheritance pattern and on which of the
functional domain of TECTA was affected (Hildebrand et al.,
2011). Thus, as expected, Sporadic Case_8, affected by autosomal
recessive NSHL, carried a splicing and a non-sense variant,
and displayed a moderately severe to severe hearing phenotype
(Asgharzade et al., 2017). As regards dominant families, the
phenotype of the patients wasmuchmore variable and not always
reflecting data of previous studies leading to new genotype-
phenotype links to be further investigated (Choi et al., 2014).
Another gene frequently mutated in our cohort of patients
turned out to be ACTG1. Two out of the three mutations
identified in this gene were detected as “de novo.” So far, several
mutations in ACTG1 gene have been described and analyzed by
protein modeling (van Wijk et al., 2003; Rendtorff et al., 2006)
although de novo ACTG1 variants seem to be a rare cause of
NSHL (Wang et al., 2018). In this light, we further investigated
their potential role by protein modeling and molecular dynamics
simulations demonstrating a significant modification of two
functional regions of the protein, the tropomyosin, and myosin
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binding sites and the D-loop. Considering that the binding
of tropomyosin and myosin to actin is a key mechanism for
regulating the normal function of the complex (Rayment et al.,
1993; Behrmann et al., 2012) and that an alteration in actin
filament regulation is an important factor in deafness caused by
ACTG1 mutations, these de novo variants likely alter the protein
activity, leading to deleterious effects (Lee et al., 2018).
Furthermore, another relevant finding of this study is the high
prevalence of X-linked forms, which are expected to account for
an inconsiderable part of the genetic forms (Smith et al., 2005)
and that have been detected in three cases of both dominant
and recessive X-linked NSHL, involving SMPX and POU3F4
genes. Among them, a careful attention should be directed to
SMPX gene whose mutations have been recently reported to
lead to a mild bilateral HL phenotype in females and a severe
to profound early-onset HL in the affected males (Niu et al.,
2017). Alternatively, as in the case of our family, the mother
shows a monolateral severe to profound (sky-slope) HL while
the proband displays a post-lingual bilateral symmetric severe to
profound medium-high frequencies NSHL, as described in only
one case worldwide (Weegerink et al., 2011). For this reason,
during genetic counseling, it would be very important to carefully
verify the monolateral clinical manifestations in affected females
as an indicator of an X-linked form of HL.
Finally, our data highlight the huge importance of CNVs
discovery in TRS negative cases, or in patients carrying only one
mutated allele in recessive genes. In fact, among the 14 families
analyzed by SNP arrays, a causative CNV was identified in 5 of
them, explaining∼36% of cases.
In particular, this approach allowed the detection of a
paternal UPD in chromosome 18, involving LOXHD1 gene. This
represents the second example of UPD associated to NSHL,
in addition to that one described in GJB2, the most common
mutated HL gene. In fact, the only cases of UPD so far described
as causative of hearing loss, affect GJB2 gene (Yan et al., 2007).
Furthermore, CNVs analysis confirmed the significant
contribution of STRC deletions in hearing loss as recently
described in other populations (Plevova et al., 2017). STRC
deletions are reported in approximately 1% of mixed deafness
populations (Francey et al., 2012; Hoppman et al., 2013), making
it as a major contributor to congenital hearing impairment,
and can cause autosomal recessive NSHL (Verpy et al., 2001)
or Deafness-infertility syndrome (DIS) in males if the adjacent
CATSPER2 gene is also involved in the deletion (Zhang et al.,
2009). Considering that in Familial Case_6 the deletion also
involved CATSPER2 gene, it will be important to evaluate future
fertility problems in the male sibling (since now he is only 3 years
old).
Overall, our results proved that the combination of an
accurate clinical evaluation, TRS of known NSHL genes and SNP
arrays can effectively enhance, in a cost-effective way, the genetic
characterization of NSHL, leading to the identification of new
mutations/CNVs and thus helping in the clinical management of
patients.
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